Quarterly Results

PARMAX PHARMA LTD.

NSE : NABSE : 540359ISIN CODE : INE240T01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE29.82-1.68 (-5.33 %)
PREV CLOSE ( ) 31.50
OPEN PRICE ( ) 30.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 928
TODAY'S LOW / HIGH ( )28.20 30.55
52 WK LOW / HIGH ( ) 24.1836.58
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
13.27
40.68
14
63.82
Total Expenditure
24.81
48.32
20.52
55.46
PBIDT (Excl OI)
-11.54
-7.64
-6.52
8.36
Other Income
0.11
0.09
0.14
0.15
Operating Profit
-11.43
-7.55
-6.38
8.51
Interest
1.56
1.81
1.22
0.54
Exceptional Items
NA
NA
NA
NA
PBDT
-12.99
-9.36
-7.6
7.97
Depreciation
4.54
4.32
4.19
4.73
Profit Before Tax
-17.53
-13.68
-11.79
3.24
Tax
NA
NA
NA
1.5
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-17.53
-13.68
-11.79
1.74
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-17.53
-13.68
-11.79
1.74
Equity Capital
37.41
37.41
37.41
37.41
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-4.68
-3.65
-3.15
0.46
Calculated EPS (Annualised)
-18.74
-14.62
-12.60
1.86
No of Public Share Holdings
2588850
2588850
2588850
2588850
% of Public Share Holdings
69.2
69.2
69.2
69.2
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-86.96
-18.78
-46.57
13.09
PBIDTM%
-86.13
-18.55
-45.57
13.33
PBDTM%
-97.88
-23.00
-54.28
12.48
PBTM%
-132.10
-33.62
-84.21
5.07
PATM%
-132.10
-33.62
-84.21
2.72
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.